Lundbeck buys rights for Alzheimer's treatment - Forbes
Lundbeck buys rights for Alzheimer's treatment Forbes, NY - ... it has acquired the European commercialisation rights for Flurizan, a phase III drug candidate that may have the potential to treat Alzheimer's disease, ... Myriad Genetics Sells Flurizan Rights Myriad Genetics Selects Lundbeck as European Partner for Flurizan Lundbeck: Myriad Deal is a High Risk High Reward Strategy |
Original post: Lundbeck buys rights for Alzheimer's treatment - Forbes by ©2008 Google at alzheimers treatment - Google News
Blog tag: Alzheimers treatment
Technorati tag: Alzheimers treatment